Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors

Brain Research

Volumn 816, Issue 2, 1999, Pages 309-316

  Morita, Kyoji ^a   Ishimura, Kazunori ^a   Tsuruo, Yoshihiro ^a   Wong, Dona L ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxicity; Dexamethasone; Glucocorticoid receptor; Necrosis; Rat C6 glioma cell; Serum deprivation

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; DEXAMETHASONE; GLUCOCORTICOID ANTAGONIST; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CYTOTOXICITY; DNA DEGRADATION; GEL ELECTROPHORESIS; GLIA CELL; GLIOMA CELL; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANDROSTANOLS; ANIMALS; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; DEXAMETHASONE; DNA, NEOPLASM; GLIOMA; GLUCOCORTICOIDS; MICROSCOPY, ELECTRON; NECROSIS; NEUROGLIA; NEURONS; RATS; RECEPTORS, GLUCOCORTICOID; TUMOR CELLS, CULTURED;

EID: 0033596505     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01093-2     Document Type: Article

References (41)

1. 2+ concentration in gerbil hippocampus. J. Cereb. Blood. Flow Metab. 18:1998;274-280.
2. Bishop J., Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell. Neurosci. 5:1994;303-308.
3. Coirinl H., Magarinos A.M., De Nicola A.F., Rainbow T.C., McEwen B.S. Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res. 361:1985;212-216.
4. Couldwell W.T., Hinton D.R., He S., Chen T.C., Sebat I., Weiss M.H., Law R.E. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 345:1994;43-46.
5. Coyle D.E. Identification of a collagen-potentiated neurite promoting factor (CPNPF) isolated from C6 glioma cells. J. Neurosci. Res. 35:1993;390-401.
6. Coyle D.E. Adaptation of C6 glioma cells to serum-free conditions leads to the expression of a mixed astrocyte-oligodendrocyte phenotype and increased production of neurite-promoting activity. J. Neurosci. Res. 41:1995;374-385.
7. Elliott E.M., Sapolsky R.M. Corticosterone impairs hippocampal neuronal calcium regulation - possible mediating mechanisms. Brain Res. 602:1993;84-90.
8. Fautz R., Husein B., Hechenberger C. Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat. Res. 253:1991;173-179.
9. Gomez-Sanchez C.E., Gemez-Sanchez E.P. RU-26988 - a new tool for the study of the mineralocorticoid receptor. Endocrinol. 113:1983;1004-1009.
10. Gruol D.J., Rajah F.M., Bourgeois S. Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells. Mol. Endocrinol. 3:1989;2119-2127.
11. Hou J.-G.G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69:1997;76-83.
12. Kentroti S., Baker R., Lee K., Bruce C., Vernadakis A. Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells. J. Neurosci. Res. 28:1991;497-506.
13. Koide T., Wieloch T.W., Siesjö B.K. Chronic dexamethasone pretreatment aggravates ischemic neuronal necrosis. J. Cereb. Blood Flow Metab. 6:1986;395-404.
14. Kozlova M., Kentroti S., Vernadakis A. Maintenance of glial plasticity with aging in C-6 glial cells and normal astrocytes in culture: responsiveness to opioid peptides. J. Neurosci. Res. 36:1993;570-579.
15. Lam M., Dubyak G., Distelhorst C.W. Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells. Mol. Endocrinol. 7:1993;686-693.
16. Landfield P.W., Thibault O., Mazzanti M.L., Porter N.M., Kerr D.S. Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis. J. Neurobiol. 23:1992;1247-1260.
17. Landfield P.W., Waymire J.C., Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlation. Science. 202:1978;1098-1102.
18. 2+ concentration. Arch. Biochem. Biophys. 269:1989;365-370.
19. McEwen B.S., DeKloet E.R., Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66:1986;1121-1188.
20. McGinnis J.F., de Vellis J. Glucocorticoid regulation in rat brain cell cultures. Hydrocortisone increases the rate of synthesis of glycerol phosphate dehydrogenase in C6 glioma cells. J. Biol. Chem. 253:1978;8492-8493.
21. Morris R.G., Hargreaves A.D., Duvall E., Wyllie A.H. Hormone-induced cell death: 2. Surface changes in thymocytes undergoing apoptosis. Am. J. Pathol. 115:1984;426-436.
22. Morse J.K., Davis J.N. Regulation of ischemic hippocampal damage in the gerbil: Adrenalectomy alters the rate of CA1 cell disappearance. Exp. Neurol. 110:1990;86-92.
23. Pauwels P.J., Van Assouw H.P., Leysen J.E. Attenuation of neurotoxicity following anoxia or glutamate receptor activation in EGF- and hippocampal-extract-treated neuronal cultures. Cell Signal. 1:1989;45-54.
24. Pishak M.R., Phillips A.T. Glucocorticoid stimulation of glutamine synthetase production in cultured rat glioma cells. J. Neurochem. 34:1980;866-872.
25. Raynaud J.P., Bouton M.M., Moguilewsky M., Ojasoo T., Philibert D., Beck G., Labrie F., Mornon J.P. Steroid hormone receptors and pharmacology. J. Steroid Biochem. 12:1980;143-157.
26. Rosenberg P.A., Aizenman E. Hundredfold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 103:1989;162-168.
27. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability. Brain Res. 359:1985;300-305.
28. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J. Neurosci. 5:1985;1228-1232.
29. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J. Neurosci. 6:1986;2240-2244.
30. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: Temporal aspects of synergy with kainic acid. Neuroendocrinology. 43:1986;440-444.
31. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 5:1985;1222-1227.
32. Sapolsky R.M., Packan D.R., Vale W.W. Glucocorticoid toxicity in the hippocampus: in vitro demonstration. Brain Res. 453:1988;367-371.
33. Sapolsky R.M., Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science. 229:1985;1397-1400.
34. Smith-Swintosky V.L., Pettigrew L.C., Sapolsky R.M., Phares C., Craddock S.D., Brooke S.M., Mattson M.P. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J. Cereb. Blood Flow Metab. 16:1996;585-598.
35. Strijbos P.J.L.M., Relton J.K., Rothwell N.J. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Brain Res. 656:1994;405-408.
36. Tombaugh G.C., Yang S.H., Swanson R.A., Sapolsky R.M. Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. J. Neurochem. 59:1992;137-146.
37. Vedeckis W.V., Bradshaw J., Bradshaw J. DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents. Mol. Cell. Endocrinol. 30:1983;215-227.
38. Vibulsreth S., Hefti F., Ginsberg M.D., Dietrich W.D., Busto R. Astrocytes protect cultured neurons from degeneration induced by anoxia. Brain Res. 422:1987;303-311.
39. Virgin C.E. Jr., Ha T.P.-T., Packan D.R., Tombaugh G.C., Yang S.H., Horner H.C., Sapolsky R.M. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: Implication for glucocorticoid neurotoxicity. J. Neurochem. 57:1991;1422-1428.
40. Westermann R., Hardung M., Meyer D.K., Ehrhard P., Otten U., Unsicker K. Neurotrophic factors released by C6 glioma cells. J. Neurochem. 50:1988;1747-1758.
41. Wyllie A.H., Morris R.G. Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am. J. Pathol. 109:1982;78-87.